Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
616
|
281
|
0.340 |
None |
1.000 |
1 |
|
2007 |
2020 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
217
|
|
0.330 |
None |
1.000 |
1 |
|
2007 |
2019 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
616
|
1
|
0.320 |
None |
1.000 |
1 |
|
2007 |
2008 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
702
|
856
|
0.320 |
None |
1.000 |
1 |
|
2012 |
2017 |
Endometriosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
161
|
80
|
0.320 |
None |
1.000 |
1 |
|
2013 |
2018 |
Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
174
|
1789
|
0.310 |
None |
1.000 |
1 |
|
2013 |
2017 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
84
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Drug Dependence
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Substance abuse problem
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
116
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Cognition Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
38
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Complications of Diabetes Mellitus
|
group |
Endocrine System Diseases
|
Disease or Syndrome
|
11
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Endometrioma
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
161
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Substance-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
18
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
84
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Substance Use Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Substance Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
1
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Colorectal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
277
|
586
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Organic Mental Disorders, Substance-Induced
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Drug abuse
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
1
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Drug habituation
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Drug Use Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Prescription Drug Abuse
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Finding
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |